John SchroyerSeptember 13, 2023
The initiative has already helped fund two research programs in Sweden.
Tag: psychedelics
John SchroyerSeptember 13, 2023
Debra BorchardtAugust 29, 2023
Silo Wellness, Inc. (CSE: SILO) (OTCQB: SILFF) is buying NUGL Inc. (OTC Pink: NUGL) in a deal valued at C$43 million. Last month Silo announced it was partnering with Jamaica-based Kaya Group, which is owned by Nugl. Nugl and Kaya merged in April 2022 to form a multifaceted cannabis lifestyle company. The company operates three […]
Adam JacksonAugust 29, 2023
Cybin and Small Pharma holders will own around 74.5% and 25.5% of the combined company, respectively.
Debra BorchardtAugust 15, 2023
Mydecine Innovations Group (OTC: MYCOF) released the barest of financial results for the quarter ending June 30, 2023. There is no revenue to report. The net loss attributable to common stockholders was $3.18 million, from operations, or a basic and diluted loss per share of $(0.13). For the same period in 2022, the loss from […]
Debra BorchardtAugust 9, 2023
Atai noted it was exploring strategic options for the study.
Adam JacksonAugust 1, 2023
The company is operating on a going concern basis.
Debra BorchardtJuly 24, 2023
Enveric Biosciences (NASDAQ: ENVB) announced the successful completion of preclinical ADME and toxicology studies for its lead candidate EB-373. EB-373 EB-373, is defined as a New Chemical Entity or NCE. According to the company it is designed as a next-generation proprietary psilocin prodrug and developed leveraging the company’s Psybrary drug discovery platform to target anxiety […]
Adam JacksonJuly 19, 2023
Benjamin Lightburn will remain in his role as CEO.
Adam JacksonJuly 18, 2023
The company's also cutting costs and streamlining where it can to grab more margin.
Emerson BrownJune 19, 2023
Most North American Blacks say they have little-to-no participation with psychedelics.
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.